Posted in | News

European Court of Justice Rules in SGL Carbon Graphite Electrode Case

The European Court of Justice (ECJ) has announced its ruling on the graphite electrode case and changed both the verdict of the European Court of April 29, 2004 as well as the ruling of the European Commission of July 18, 2001 to €75.7 million. With this decision the ruling becomes legally binding.

The judgement of the ECJ does not reflect the internationally accredited principle of double jeopardy (ne bis in idem). In 1999 the US Department of Justice imposed a fine against SGL Carbon in the same case. Therefore and despite the reduction of the fine in the first juridical instance, SGL sought principal ruling by the ECJ. Based on expert opinions of judicial science and practice SGL Carbon was confident that the ECJ would substantially reduce the fine under the principle of ne bis in idem. The ECJ however did not do this in spite of many strong legal arguments, and ultimately decided to side with the European Commission.

Due to this ruling the Company will now undertake adjustments in its provisions, leading to a negative impact on EBIT in the second quarter of €23.5 million and on the financial result of €12.7 million.

As reported in April, the fine together with accumulated interest have been cash funded with the EU Commission without accepting the fine. Today’s verdict therefore only has a negative cash impact of €8.5 million in the second quarter. SGL maintains its guidance on net financial debt for the year end.

These measures will be implemented in the 2nd Quarter 2006 balance sheet and profit and loss statement on which the Company will inform on July 26, 2006 within the framework of our half year result reporting.

http://www.sglcarbon.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.